Muscle Loss on a GLP-1 During Menopause: What the Data Shows

Between a quarter and 40 percent of total weight lost, depending on the trial and how it was measured. That is the honest range, and it is neither as reassuring nor as alarming as the two loudest camps online suggest.

The most cited number comes from the STEP 1 body composition substudy (Wilding et al., NEJM 2021), where a subset of participants underwent DXA scanning. Of the total weight lost on semaglutide 2.4 mg, roughly 39 percent was lean body mass. That sounds bad in isolation. But the same substudy found that lean mass as a *proportion* of total body weight actually improved, from 61.2 percent to 63.8 percent, because fat was lost faster than muscle.

The SURMOUNT-1 body composition substudy for tirzepatide found a similar pattern, with fat mass falling substantially more than lean mass, producing roughly a 3-to-1 fat-to-lean loss ratio.

Two important caveats on those numbers.

First, "lean mass" on a DXA scan is not the same thing as muscle. It includes water, glycogen, connective tissue and organ mass. A meaningful share of early lean mass loss is glycogen and its associated water, which is not a functional loss.

Second, this ratio is not unique to GLP-1 medications. Caloric restriction of any kind produces lean mass loss in roughly the same proportion. What is different is the magnitude and the speed. Someone who would have plateaued at 8 percent weight loss on a diet is now losing 20 percent, so the absolute amount of lean tissue leaving the body is larger.

The practical question is not whether you will lose some lean mass. You will. It is whether you end up with enough functional muscle to carry you through the next thirty years.

Because menopause is already an accelerated muscle loss event, and you are adding a caloric deficit on top of it.

Women lose skeletal muscle mass at roughly 0.6 percent per year after menopause, with data from longitudinal cohorts suggesting the transition itself, not chronological age alone, is the inflection point. Three mechanisms drive it:

Estrogen withdrawal. Estrogen receptors are present in skeletal muscle and influence satellite cell function, the repair machinery that rebuilds muscle after training. When estrogen falls, the repair response is blunted and recovery from the same workout takes longer.

Anabolic resistance. Older muscle requires a higher dose of dietary protein to trigger the same muscle protein synthesis response. A 25-year-old gets a robust response from about 20 g of high-quality protein. A 60-year-old may need 35 to 40 g at the same meal to hit the same signal. This is well documented and it is why the standard 0.8 g/kg RDA is badly out of date for midlife women.

Reduced muscle quality, not just quantity. Studies of the menopause transition find declines in force per unit of muscle cross-sectional area, meaning the muscle you still have produces less force. Intramuscular fat infiltration increases.

Now layer a GLP-1 on top. Appetite suppression makes hitting a higher protein target harder, not easier. Slowed gastric emptying means large protein meals feel impossible. Nausea on injection day can cost you an entire day of intake. Fatigue reduces training volume.

This is the same structural problem we described for [bone density on a GLP-1 in menopause](/blog/glp1-bone-density-in-menopause-the-double-risk): two independent risk factors converging in the same person at the same time, and neither one being managed because each specialist only sees their half.

You do not need a DXA scan, though one is useful if it is affordable. Three validated functional tests will tell you most of what you need to know, and you can do all of them at home.

Grip strength. The single best-studied proxy for whole-body strength and a strong predictor of mortality and disability. The European Working Group on Sarcopenia (EWGSOP2, 2019) uses a cutoff of under 16 kg for women as a marker of probable sarcopenia. A hand dynamometer costs about $25. Test your dominant hand, take the best of three, and repeat monthly. A downward trend over three months while you are losing weight is a signal to change something. More on this in our [grip strength guide](/blog/grip-strength-on-glp1-the-muscle-marker-that-matters).

Five-times sit-to-stand. From a standard chair, arms crossed over your chest, stand up and sit down five times as fast as you safely can. More than 15 seconds indicates poor lower-body function. This one is sensitive to leg muscle specifically, which is where most functional decline shows up first.

Gait speed. Walk 4 metres at your normal pace. Under 0.8 m/s (roughly 5 seconds for 4 metres) is the standard cutoff for severe sarcopenia.

Alongside these, watch the subjective signals: stairs feeling harder than they did three months ago, groceries feeling heavier, needing to push off the armrest to stand. Those are not vanity concerns. They are the early edge of the functional decline that determines independence in your seventies.

One measurement to be sceptical of: bioimpedance scales (the ones that report body fat percentage from your bathroom). They are heavily influenced by hydration, and hydration changes dramatically on a GLP-1. Trending them week to week produces noise, not signal.

1.2 to 1.6 g per kg of body weight per day, distributed as 25 to 40 g per meal, with an emphasis on getting the highest-protein meal in when your appetite is best.

For a 75 kg (165 lb) woman, that is 90 to 120 g daily. Compare that to the RDA of 0.8 g/kg, which would give 60 g, a number derived from nitrogen balance studies in young men and never intended as an optimum for midlife women in a caloric deficit.

The per-meal distribution matters as much as the daily total because of the leucine threshold. Muscle protein synthesis is triggered when a meal delivers roughly 2.5 to 3 g of leucine, which corresponds to about 25 to 30 g of high-quality protein in a younger person and closer to 35 to 40 g in an older one. Eating 20 g at breakfast, 20 g at lunch and 70 g at dinner delivers the same daily total as three 37 g meals but triggers the synthesis signal once instead of three times.

On a GLP-1 this is genuinely hard, and the standard advice to "just eat more protein" is not useful. What works in practice:

• •Front-load. Appetite is usually highest in the morning and worst 24 to 48 hours after injection. Get 35-40 g at breakfast on your best days.
• •Go liquid when solid food is impossible. A shake with 40 g of protein takes 90 seconds to drink and bypasses the volume problem entirely. Our [GLP-1 smoothie recipes](/blog/glp1-smoothies-high-protein-recipes-for-low-appetite-days) are built for this.
• •Plan around the injection. If Monday injections mean Tuesday is a write-off, load protein on Sunday and Wednesday rather than fighting Tuesday.
• •Prioritize protein first on the plate. When you can only eat a third of your meal, eating the chicken before the rice changes the outcome.

On creatine: 3 to 5 g daily has reasonable evidence in postmenopausal women for supporting lean mass and strength when combined with resistance training, and it is one of the cheapest and best-studied supplements available. It is not a substitute for protein or training. We cover the evidence in [creatine for menopause](/blog/creatine-for-menopause-what-the-evidence-actually-shows).

Progressive resistance training, two to three sessions per week, full body, with enough load that the last two or three reps of each set are genuinely hard.

That last clause is where most programs fail. Walking is excellent for cardiovascular health, adherence and appetite regulation, and it is not a muscle preservation stimulus. Neither is a bodyweight class you have been doing at the same intensity for two years. Muscle responds to progressive overload, meaning the demand has to increase over time.

A workable minimum:

• •2 sessions per week, 30 to 40 minutes each
• •5 to 6 compound movements per session: a squat pattern, a hinge pattern, a horizontal push, a horizontal pull, a vertical push or pull, and a carry
• •2 to 3 sets of 6 to 12 reps per movement
• •Add load or reps every one to two weeks

The compound movements matter more than the variety. A woman doing goblet squats, Romanian deadlifts, dumbbell bench press, rows and farmer's carries twice a week, adding weight when she can, will preserve more muscle than someone doing twelve different machines with no progression.

Two menopause-specific adjustments: recovery takes longer. Blunted satellite cell response means 48 to 72 hours between sessions hitting the same muscle group, rather than 24 to 48. And do not train fasted on a GLP-1 if you can avoid it. Low glycogen plus low protein availability plus a deficit is a poor environment for retaining tissue.

On the days nausea makes training feel impossible, doing something is better than nothing, and something light is better than skipping the week entirely. Our [weekly plan for exercising on a GLP-1 in menopause](/blog/exercise-on-glp1-during-menopause-a-realistic-weekly-plan) has a structure that accounts for injection-day fatigue.

The last lever, and the one people forget, is rate of loss. Losing 0.5 to 1 percent of body weight per week preserves more lean mass than losing 2 percent. If you are hitting your protein target, training hard, and still watching grip strength fall, the answer may be to hold your dose rather than escalate.